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Abstract
Recent genetic studies and whole-genome sequencing projects have greatly improved our
understanding of human variation and clinically actionable genetic information. Smaller eth-
nic populations, however, remain underrepresented in both individual and large-scale
sequencing efforts and hence present an opportunity to discover new variants of biomedical
and demographic significance. This report describes the sequencing and analysis of a
genome obtained from an individual of Serbian origin, introducing tens of thousands of previ-
ously unknown variants to the currently available pool. Ancestry analysis places this individ-
ual in close proximity to Central and Eastern European populations; i.e., closest to Croatian,
Bulgarian and Hungarian individuals and, in terms of other Europeans, furthest from Ashke-
nazi Jewish, Spanish, Sicilian and Baltic individuals. Our analysis confirmed gene flow
between Neanderthal and ancestral pan-European populations, with similar contributions to
the Serbian genome as those observed in other European groups. Finally, to assess the
burden of potentially disease-causing/clinically relevant variation in the sequenced genome,
we utilized manually curated genotype-phenotype association databases and variant-effect
predictors. We identified several variants that have previously been associated with severe
early-onset disease that is not evident in the proband, as well as putatively impactful variants
that could yet prove to be clinically relevant to the proband over the next decades. The pres-
ence of numerous private and low-frequency variants, along with the observed and pre-
dicted disease-causing mutations in this genome, exemplify some of the global challenges
of genome interpretation, especially in the context of under-studied ethnic groups.
Introduction
The genetic variation between individuals accounts for much of observed human diversity and
has the potential to provide information on phenotypic outcomes of clinical consequence.
Studies of genetic variation provided by individual genome sequences have revealed that this
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variation differs both within and between populations, and also varies considerably depending
upon the population [1]. Moreover, characterization of genetic variation of individuals from
multiple populations has revealed a correlation between genetic and geographic distances, and
has become relevant for determining genetic ancestry and geographic origin [2–6]. Therefore,
the characterization of genetic variation has been of major interest for diverse research fields,
including medical, biological and anthropological sciences [2–10].
Sequencing of the first human genomes revealed that most genetic variation is derived
from single nucleotide variants (SNVs), although insertions and deletions (indels) account for
the majority of the variant nucleotides [11]. The increased accessibility of DNA sequencing
has contributed to individual efforts from a range of distinct populations. To date, individual
genomes from American [11, 12], Han Chinese [13], Russian [14], Khoisan [15], Bantu [15],
Japanese [16], German [17], Gujarati Indian [18], Estonian [19], Pakistani [20] and Mongolian
[21] populations have been sequenced and analyzed, among many others [1].
Larger-scale efforts to characterize human genetic variation have demonstrated that indi-
viduals from different populations carry particular combinations of rare and low-frequency
variants. The 1000 Genomes Project Consortium has estimated that 86% of all variants are
confined to a single continental group and that about 10% of variants observed in a population
are private to that population [1]. Population-specific variants have the potential to be of both
functional and biomedical importance [7, 22–24]. Furthermore, evidence of biologically mean-
ingful population-specific variation [25] emphasizes the need for ethnically relevant reference
genomes, as has been performed, for example, for the Korean population [26]. Although we
are not claiming to have introduced a new reference genome here, it is nevertheless important
to expand our sequencing efforts across diverse populations, particularly those that have not
been previously studied [10, 27].
In this paper, we describe the sequencing of the first genome of an individual of Serbian
origin, a member of a relatively small population in Central to Southeastern Europe. We
identify tens of thousands of novel genetic variants in this individual, more than a hundred
of which map to protein-coding regions and several hundred of which reside in close proxim-
ity to gene coding regions. The extent of observed genetic variation allowed comparisons
with extant European populations and reaffirms support for the hypothesis of close corre-
spondence between genetic and geographic distances [2]. These results contribute to ongoing
efforts to understand human genetic variation and its geographic distribution, as well as plac-
ing the Serbian genome within the context of the broader European population structure.
Testing for Neanderthal introgression in the genome, we find evidence to suggest gene flow
from Neanderthal to an ancestral pan-European genome, with the Serbian genome being
placed within the range of other European populations. After variant annotation, we assess
the burden of potentially pathogenic variation present in this genome and identify variants of
putative clinical and pharmacogenetic relevance. Finally, we draw conclusions pertaining to
the phenotypic consequences and biomedical interpretation of individually sequenced
genomes.
Materials and methods
Donor information
The individual whose genome was sequenced and analyzed is a male of Serbian descent. The
data, both derived and raw, are publicly available through the Personal Genome Project web-
site [28], participant ID: hu3BDC4B.
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Sample collection and DNA sequencing
Two milliliters of saliva were self-collected by the donor and stored using the DNA Genotek
Oragene DISCOVER (OGR-500) sample collection kit. Extraction of DNA from the sample
and subsequent sequencing were performed at the BGI (Shenzhen, China) on an Illumina
HiSeq 2000 sequencer, using standard protocols. To minimize the likelihood of systematic bias
in sampling, two libraries were prepared with an insert size of 500 bp each, with paired-end
reads of length 90 bp. Sequencing was then carried out in four lanes for each library to ensure
at least 30-fold coverage.
Read mapping and variant calling
Single Nucleotide Variants (SNVs) and indels were called using four different pipelines
through a combination of two read mappers and two variant callers. The GRCh37 human
genome was used as the reference genome to map the paired-end reads. The two read mappers
used were BWA-MEM [29] and Bowtie2 [30]. The two variant callers were GATK [31] and
Platypus [32]. The GATK pipeline included additional read and variant processing steps such
as duplicate removal using Picard tools [33], base quality score recalibration, indel realign-
ment, and genotyping and variant quality score recalibration using GATK, all used according
to GATK best practice recommendations [34, 35].
As described later in the Results, variants identified using the BWA+ GATK pipeline were
used for all downstream analysis. Variants in the intersection of all four pipelines (two read
mappers and two variant callers) were considered to be confidently identified, where the inter-
section is defined as variant calls for which the chromosome, position, reference, and alternate
fields in the VCF files were identical. All variant calls were subsequently annotated with
information from NCBI RefSeq using ANNOVAR [36]. We estimated the amount of novel
variation expected to be observed from the first individual in a previously uncharacterized
population utilizing the 1000 Genomes Project Phase 3 VCF files [37]. To do this, we carried
out a leave-one-population-out procedure; i.e., we excluded one of the 26 populations at a
time and for each individual in the excluded population, calculated the fraction of variants not
seen in any of the individuals from the remaining 25 populations. The calculated fractions of
novel variants were used to understand the expected novelty when sequencing an individual
from a new population, given a sample of a particular size of previously sequenced individuals
from different populations.
Structural variants (SVs) were called using Structural Variation Engine (SVE) and FusorSV
[38]. SVE is an execution engine for an ensemble of SV calling algorithms containing Break-
Dancer [39], BreakSeq2 [40], cnMOPS [41], CNVnator [42], DELLY [43], GenomeSTRiP [44,
45], Hydra [46], and LUMPY [47]. The Docker image of SVE was used to run all the stages
with default parameters. All but GenomeSTRiP completed without errors. The Docker image
of FusorSV was then used to merge the results from the remaining seven SV callers, using the
default fusion model. SVint [48] was used to subsequently annotate the structural variants.
Scripts and documentation for parameters used to run all the pipelines described in this study
were added to the Personal Genome Project website, participant ID hu3BDC4B.
Principal component analysis
Principal component analysis (PCA) was carried out using the smartpca program from
EIGENSOFT (v6.0.1; https://github.com/DReichLab/EIG), on the Serbian genome combined
with the SNV data (600,841 loci) from Lazaridis et al. [3]. Only the subset of European individ-
uals from their curated fully public dataset was used, reducing the original set of 1,964
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individuals to 260. A projection to the first two principal components was used to establish the
correspondence between genetic and geographic distance in our results.
Neanderthal introgression
To test for Neanderthal introgression in the Serbian genome, we computed D-statistics [49,
50] using this genome and the dataset from Lazaridis et al. [9]. This dataset includes 294
ancient individuals (only one of which was used here) and a diverse set of 2,068 present-day
humans, genotyped on the Affymetrix Human Origins array. Both the archaic and modern
genotype data were provided in the PACKEDANCESTRYMAP format, and were combined
using the mergeit program from EIGENSOFT (v6.1.2; https://github.com/DReichLab/
EIG). The merged dataset, in total, contains 2,362 samples genotyped at 621,799 SNV loci.
Upon request, we completed the consent form and obtained approval from David Reich’s lab-
oratory before using this dataset. Some individuals from the study of Lazaridis et al. [9] could
not be included due to consent issues relating to data distribution.
We next genotyped the Serbian genome against these predefined SNVs using GATK Haplo-
typeCaller and following the GATK best practices recommendations [34, 35]. We converted
the resulting VCF files to the EIGENSTRAT format using VCFtools (v0.1.12a, [51]), and inte-
grated the Serbian genotype with the modern and ancient datasets. Finally, we ran qpDstat
from AdmixTools (default setting, v701) to calculate D-statistics and to test for Neanderthal
gene flow into the Serbian genome [50].
Burden of pathogenic variation
Variants of putative clinical significance were identified using genotype-phenotype databases
as well as computational variant-effect prediction. Manually curated genotype-phenotype
databases, such as the Human Gene Mutation Database (HGMD) [52], ClinVar [53] and
PharmGKB [54], annotate variants with a known relationship to phenotype [52, 55]. Clinical
Annotations from PharmGKB were compared against dbSNP v142 rsIDs [56] obtained using
the annotate_variation.pl script in ANNOVAR and avsnp142. Variants identified by GATK
were compared against HGMD and ClinVar to identify potentially disease-causing and dis-
ease-associated mutations.
All variants in protein-coding regions were extracted and inputted to the MutPred suite
of tools [57–60]. The remaining variation observed in the proband was interrogated using
CADD [61]. For disease and gene ontology associations, the hypergeometric test in WebGes-
talt was used with Benjamini-Hochberg correction for multiple hypothesis-testing [62]. The
background set that was used for these analyses included all protein-coding genes from the
human reference genome. For the significance of an ontology term to be confirmed, at least
five genes were required to be associated with it.
Results
Effect of genotyping software
The choice of computational tools and their parameters in processing raw sequencing reads
can significantly impact the resulting genome and the entirety of subsequent analysis [63, 64].
To understand the uncertainty of variant identification in our subject, we evaluated two differ-
ent read mappers, BWA-MEM [29] and Bowtie2 [30], and two different variant callers, GATK
[31] and Platypus [32].
The results from four different platforms are compared and contrasted in Fig 1. The SNV
calling shows good concordance between both read mappers and variant callers, with a large
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proportion of variants identified by either platform being identified by all platforms. Using the
BWA-MEM mapper (which we refer to simply as “BWA” from now on), for example,
2,991,390/3,280,434 = 91.2% of SNVs identified by GATK were also identified by Platypus and
89.1% of SNVs identified by Platypus were also identified by GATK (Fig 1). Indel calling, on
the other hand, is less reliable, with 401,082/627,519 = 63.9% variants identified by GATK also
identified by Platypus and only 66.7% of variants identified by Platypus being also identified
by GATK. The influence of read mappers was markedly lower; i.e., using the GATK variant
caller, we found that 95.1% of SNVs and 89.3% of indels identified with BWA were also identi-
fied with Bowtie2, and 98.3% SNVs and of 97.6% of indels identified with Bowtie2 were also
identified with BWA. Smaller percentages of overlap were observed for Platypus. Based on the
results observed in this work (Table A in S1 File) and the extent of usage of these tools in rese-
quencing human genomes, we selected BWA+ GATK as our main platform.
Identification of genetic variants
The genome of a Serbian individual was sequenced according to the protocols described in the
Materials and Methods, with all 22 autosomes having similar coverage and the X and Y chro-
mosome having approximately half this coverage. The genome sequencing and mapping
achieved an average read depth of 34.7, with 98.3% of GRCh37 reference bases having coverage
of 10-fold or more and 89.4% having coverage of 20-fold or more. The number of zero-depth
positions were 7,649,443 (0.3%). The coverage distribution is shown in the Supporting Infor-
mation (S1 Fig).
Using the BWA+ GATK pipeline, we identified a total of 3,908,814 variants (83.9% SNVs,
16.1% indels; Fig 1) in the Serbian genome, of which 2,195,638 (56.2%) were heterozygous
with one non-reference allele, 23,095 (0.6%) were heterozygous with two non-reference alleles,
and 1,690,081 (43.2%) were homozygous for a non-reference allele. The reported variants
passed all quality filters of GATK (marked as “PASS”) and were subsequently mapped to
GRCh37 human reference genomic regions using ANNOVAR [36]. It is important to mention
that ANNOVAR considers all heterozygous positions with both alternative alleles as two
Fig 1. Venn diagrams showing the total numbers of identified variants using two read mappers (BWA [29], Bowtie2 [30]) and two variant callers (GATK [31],
Platypus [32]).
https://doi.org/10.1371/journal.pone.0208901.g001
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different variants. Mechanisms by which heterozygous alternative alleles can arise include
sequencing errors and highly variable sites, some of which are tri-allelic because of rare muta-
tional events [65]. Therefore, the resulting genome contains a total of 3,931,909 variants, of
which 2,940,042 (74.8%) were identified by all four platforms and are considered to be confi-
dent identifications. Unsurprisingly, the majority of identified variants were found to reside
in the more expansive and less evolutionarily constrained intergenic and intronic regions
(Table 1).
To identify novel variation, we compared the identified variants against the Genome Aggre-
gation Database (gnomAD) [66]. We found that 1.5% (60,153) all variants and 0.4% (12,439)
of confident variants were not present in gnomAD. We shall refer to these variants as “novel”
and “confident novel” variants, respectively. The breakdown of all variants and novel variants
with respect to genomic location is shown in Tables 1 and 2. The percentage of novel variants
varied across categories, comprising 0.9% (80) of nonsynonymous variants, 0.4% of synony-
mous variants, 0.7% (145) of exonic variants, 1.5% (20,531) of intronic variants, and 1.6%
Table 1. Summary of identified variants using BWA+ GATK. Variants not present in gnomAD [66] are listed as novel and variants identified by all four genotyping plat-
forms are listed as confident.
Type of Variant Variant Novel Confident variants Confident novel
upstream 23094 320 16211 90
upstream; downstream 881 8 624 4
UTR5 5205 54 4055 22
UTR5; UTR3 16 1 12 0
exonic 20706 145 17114 115
exonic; splicing 33 1 22 0
splicing 151 0 107 0
intronic 1410507 20531 1078226 4336
UTR3 31066 409 24095 101
downstream 26685 398 19351 61
ncRNA_exonic 13064 129 9520 30
ncRNA_exonic; splicing 3 0 2 0
ncRNA_intronic 235936 3376 173168 832
ncRNA_splicing 65 1 51 0
ncRNA_UTR5 1 1 0 0
intergenic 2164496 34779 1597484 6848
https://doi.org/10.1371/journal.pone.0208901.t001
Table 2. Summary of identified exonic variants using BWA+GATK. Variants not present in gnomAD [66] are listed as novel and variants identified by all four platforms
are listed as confident.
Type of Variant Variants Novel Confident variants Confident novel
synonymous SNV 10381 42 8965 36
nonsynonymous SNV 9328 80 7559 69
nonframeshift deletion 137 2 62 0
nonframeshift insertion 117 3 58 0
frameshift deletion 103 6 45 4
frameshift insertion 74 3 37 1
stopgain 87 6 54 4
stoploss 11 0 9 0
unknown 501 4 347 1
https://doi.org/10.1371/journal.pone.0208901.t002
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(34,779) of intergenic variants. We found that 45.0% (9,328/20,739) of the exonic variants
were nonsynonymous, whereas 50.1% (10,381/20,739) were synonymous. Similar fractions
were observed for the confident variants (44.1% vs. 52.3%). Of the 3,871,756 GATK variants
that are also observed in the gnomAD database, 3,805,264 (95%) of these variants are anno-
tated to have allele frequency greater than 1% in gnomAD and 3,676,638 (95%) with allele fre-
quency greater than 5%. The proportion of novel variation in the Serbian individual is at the
lower end of the distribution compared to 1000 Genomes Project participants (S6 Fig), consis-
tent with a significantly larger size of gnomAD that currently integrates 15,708 whole-genomes
and 125,748 exomes.
Using SVE and FusorSV, we identified 848 deletions and 3 duplications, which include the
most confident calls generated by FusorSV after merging call-sets from seven different SV-call-
ers using the default fusion model. The numbers of structural variants called by individual SV-
callers are reported in (Table B in S1 File). The deletions in the Serbian genome have a length
distribution (S7 Fig) similar to the deletions in the 27 deep-coverage samples of the 1000
Genomes Project reported by FusorSV [38]. The lengths of the three duplications are 313101,
362391 and 471821 bp. We used SVint to annotate the functional impact of the structural vari-
ants. The genes that overlap with the identified structural variants are listed in S1 File Tables C
and D.
Genetic variation and geographic distance
The projection of the Serbian individual to the first and second principal components against
European groups from [3] confirms that individuals from the same geographic region cluster
together (Fig 2). We clearly distinguish clusters of major populations composed of individuals
from the same region, approximately mirroring a map of Europe. The PCA plot demonstrates
Fig 2. Principal component analysis (PCA) plot showing the proximity of the genome sequenced in this study to other European genomes. As observed in previous
studies [2, 3], genomic distance correlates with geographic distance.
https://doi.org/10.1371/journal.pone.0208901.g002
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that the genetic ancestry of the Serbian individual analyzed in the present study corresponds to
its geographic distance from other populations. It is positioned in close proximity of the Croa-
tian, Bulgarian, and Hungarian populations.
A somewhat surprising finding is the similarity of distances between the Serbian individual
and other mostly Slavic populations (Russian, Belarus, Ukrainian) relative to distances to vari-
ous Central, Western, and Southern European groups (Czech, French, English, Albanian,
Greek). The average Euclidean distance and variance between the Serbian individual and
each of the available populations in the two-dimensional space of major PCA components is
as follows: Croatian (0.016826 ± 0.010526), Bulgarian (0.033603 ± 0.000225), Hungarian
(0.037121 ± 0.000177), Czech (0.053687 ± 0.000033), Albanian (0.058875 ± 0.000117), Ukrai-
nian (0.064328 ± 0.000062), Belarusian (0.069803 ± 0.000043), Greek (0.071108 ± 0.00062),
Tuscan (0.0736441 ± 0.000028), French (0.083077 ± 0.000159), English (0.084570 ± 0.000142),
Norwegian (0.092721 ± 0.00088), Russian (0.095968 ± 0.000079), Estonian (0.098421 ±
0.000046), Finnish (0.108523 ± 0.000154), Sicilian (0.120370 ± 0.000481), Spanish (0.134602 ±
0.000776), Ashkenazi (0.156692 ± 0.000538). The three closest individuals to the Serbian
genome were of Croatian ancestry (0.0038, 0.0046, and 0.0108).
We note that combining the Serbian individual with the set of 260 European individuals
from Lazaridis et al. [3] caused 50 formerly biallelic sites to become triallelic (no monoallelic
sites became triallelic). The triallelic sites were removed from the analysis, leaving 600,791 sites
in the analysis. The smartpca program was applied to the 261-by-600,791 genotype matrix.
Gene flow with Neanderthals
Comparisons between Neanderthals and modern humans have previously revealed evidence
of gene flow from Neanderthals to Europeans [49, 50, 67, 68]. To test whether the Serbian
genome shares an excess of alleles with the Neanderthal genome, we integrated the Serbian
genotype with a published panel of ancient and modern humans (Materials and Methods). We
calculated D-statistics as a formal test for gene flow based on a four-taxon phylogeny, D(P1, P2,
P3, O), where Pi (i 2 {1, 2, 3}) are populations and O is an outgroup. Given a scenario where
gene flow is absent, the derived alleles of P3 are expected, with equal likelihood, to match those
of P1 and P2; i.e., D = 0. Alternatively, either P1 or P2 could share alleles with P3 more often
than not, in which case D deviates from zero.
We computed D(Yoruba, Serbian, Altai, Chimpanzee) for testing for gene flow between
Neanderthals (“Altai”) and the given Serbian genome. We expected a positive D value, given
previous evidence that Neanderthals exchanged more alleles with Europeans than with Afri-
cans. The test returned a D value of 0.0241 ± 0.004476, which significantly deviated from zero
(Z-score = 5.39; Table 3), suggesting gene flow between Neanderthal and the lineage leading to
the Serbian genome. To validate this result, we also ran the test for other European populations
(Table 3). D-statistics calculated for Croatian, French, Greek and Russian genomes were com-
parable to our result, all falling within the expected range of values reported in previous studies
[49, 67, 68].
We further attempted to ensure that the calculated D-statistics were unbiased. To do this,
we repeated the analysis by replacing Yoruba with Mbuti, as some of the Yoruba samples
could have had some recent European admixture. The calculation for D(Mbuti, Serbian, Altai,
Chimpanzee) yielded a D value of 0.0186 ± 0.004763 (Z-score = 3.99; Table 3), consistent with
our results using the Yoruba samples. We next checked whether the Serbian individual has ref-
erence biases in genotyping that could have inflated the D value. We performed D-statistics
tests in the form of D(other European population, Serbian, Mbuti, hg19ref) and chose Croa-
tian, French, Greek and Russian as the “other European population”. We obtained no test
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results indicating the bias of Serbian genotypes toward the reference (Croatian: 0.0054 ±
0.004183; French: 0.0038 ± 0.004078; Greek: 0.0090 ± 0.004182; Russian: 0.0074 ± 0.004192).
Analysis of medically relevant variants
The sequenced genome contains 2,343 genetic variants that are present in HGMD by virtue of
their having been previously associated with a risk of disease; the proportions of variants
within each effect category are shown in Table 4. Several homozygous variants, manually
annotated as disease-causing (DM) are observed in the genome, shown in Table 5. Of these,
Table 4. Amount of disease-causing and potentially disease-relevant variation in the Serbian genome. Identified
variants were searched against HGMD and broken down into the phenotypic categories of HGMD. Variants were bro-
ken down into exonic and noncoding as well as homozygous and heterozygous.
Exome Noncoding
Hom Het Hom Het
Disease-causing mutations (DM) 1 9 4 6
Likely disease-causing mutations (DM?) 29 51 8 31
Disease-associated polymorphisms with additional supporting functional evidence (DFP) 78 139 203 301
Disease-associated polymorphisms (DP) 233 356 189 322
Polymorphisms that affect gene/protein structure, function or expression but with no
reported disease association (FP)
63 95 95 130
The number of homozygous and heterozygous variants that are associated with variants reported in HGMD. HGMD
labels correspond to the strength and/or evidence for the relationship between variant and disease.
https://doi.org/10.1371/journal.pone.0208901.t004
Table 3. Testing gene flow with Neanderthals. The results show the D-statistic (D), its standard error (SE) and Z-score (Z) for the test using the set of populations P1, P2,
and P3, with Chimpanzee as an outgroup (O). The last two columns show ABBA vs. BABA counts over the four genomes (P1, P2, P3, O).
P1 P2 P3 O D SE Z-score ABBA BABA
Yoruba Serbian Altai Chimpanzee 0.0241 0.004476 5.393 18158 17302
Yoruba Croatian Altai Chimpanzee 0.0233 0.003192 7.302 18268 17436
Yoruba French Altai Chimpanzee 0.0266 0.003012 8.821 18284 17338
Yoruba Greek Altai Chimpanzee 0.0270 0.003034 8.906 18266 17305
Yoruba Russian Altai Chimpanzee 0.0288 0.003096 9.306 18328 17302
Mbuti Serbian Altai Chimpanzee 0.0186 0.004763 3.909 18817 18129
Mbuti Croatian Altai Chimpanzee 0.0178 0.003693 4.832 18891 18229
Mbuti French Altai Chimpanzee 0.0210 0.003532 5.941 18902 18125
Mbuti Greek Altai Chimpanzee 0.0214 0.003578 5.978 18897 18106
Mbuti Russian Altai Chimpanzee 0.0232 0.003600 6.434 18932 18074
https://doi.org/10.1371/journal.pone.0208901.t003
Table 5. Disease-causing variants observed in the proband. The table summarizes the analysis of five homozygous variants form the sequenced genome that are listed by
HGMD as disease-causing.
Gene Variant rsID Phenotype
MIR137HG NC_000001.10:g.98502934G>T rs1625579 Schizophrenia increased risk
SLC12A3 NM_000339.2:c.1670-8C>T NA Gitelman syndrome without hypomagnesaemia
DUOXA2 NM_207581.3:c.554+6C>T NA Hypothyroidism
F13A1 NM_000129.3:c.-19+12C>A rs2815822 Factor XIII deficiency
PNPLA2 NP_065109.1:p.P481L rs1138693 Myopathy late-onset
https://doi.org/10.1371/journal.pone.0208901.t005
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one is a youth-onset phenotype, Factor XIII deficiency, associated with homozygosity for the
disease-causing allele (NM_000129.3:c.-19+12C>A) in the proband’s genome. The disease
phenotypes associated with these homozygous mutations typically become apparent in child-
hood, and therefore their occurrence in a healthy adult is indicative of variable penetrance.
The other homozygous disease-causing variants result in phenotypes that have not yet been
observed in either the individual or in their family history; perhaps reflecting either low
expressivity or late-onset. Observed heterozygous disease-causing mutations are primarily
childhood-onset without presentation in the individual, although they may represent recessive
conditions; thus, their failure to manifest may not necessarily be indicative of poor reporting
or curation quality. Next, we identified several variants with pathogenic annotation in the
ClinVar database, an open-access alternative to HGMD [53]. These variants are either low-
confidence or without known family history; more details are available in the Supporting
Information (S1 File).
We also identified several variants of potential pharmacogenetic relevance using
PharmGKB. Variants in PharmGKB are assigned Clinical Annotation Levels of Evidence from
variants with preliminary evidence (Level 4) to high confidence variant-drug combinations
with medically endorsed integration into health systems (Level A1). The genome contains a
single variant with a high-confidence annotation (Level 1B): rs2228001, associated with toxic-
ity and adverse drug reaction to cisplatin, a chemotherapeutic agent. A further 17 variants
were annotated with moderate evidence to impact the dosage, efficacy, metabolism and/or tox-
icity of drugs for diverse phenotypes including chronic hepatitis C, organ transplantation
rejection, glaucoma, depression, schizophrenia, asthma, epilepsy and HIV infections, as well as
several chemotherapy drugs.
Pathogenicity prediction. In addition to known disease-associated variants, we identified
missense variants predicted to be pathogenic by MutPred2 [57]. Of the 11,206 missense vari-
ants called by GATK, 9,329 passed all quality filters (annotated as ‘PASS’). Of these, 9,305 vari-
ants were unambiguously mapped to the correct protein isoforms and hence were amenable
for prediction by MutPred2. Based on a score threshold of 0.8 (estimated 5% false positive
rate), 95 missense variants were predicted to be ‘pathogenic.’
Of these, 14 variants were found in the homozygous state and 81 were found in the hetero-
zygous state. Genes for these variants were enriched in GO terms related to peptidase activity
S8 Fig). A similar analysis for disease associations revealed that the subject may be at risk for
cardiovascular disorders (Table I in S1 File).
Next, we applied computational predictors on the remaining protein coding variation with
the MutPred family of tools. First, we assessed the pathogenicity of 180 nonsense and frame-
shifting insertion and deletion variants with MutPred-LOF [58]. From this set, we identified a
total of 7 variants with scores above the 0.5 score threshold (corresponding to a 5% false posi-
tive rate) (Table E in S1 File). Next, we assessed 279 non-frameshifting insertion and deletion
variants with MutPred-Indel and identified 12 variants described in (Table F in S1 File. Finally,
we assessed the pathogenicity of the 90 SNV splicing variants with MutPred Splice [59]. Of
these, 28 of the variants scored at least 0.6 and were therefore classified as a “Splice Affecting
Variant” by MutPred Splice. One of these variants is predicted to cause loss of natural 3’ splice
sites, two variants are predicted to interrupt cryptic 3’ splice sites, and three variants are pre-
dicted to disrupt cryptic 5’ splice sites, described in the Supporting Information (Table G in
S1 File).
To ensure assessment of the complete variome of the proband, we utilized CADD v1.3 [61]
to evaluate all noncoding variants. To do this, we utilized a scaled C-score cutoff of 20 to iden-
tify the 1% most damaging variants. In total, we found 16 UTR variants, 1,630 intronic vari-
ants, 3,911 intergenic variants, 80 regulatory variants, 839/533 upstream/downstream variants,
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and 9 variants annotated as “noncoding_change.” All of these were predicted to be deleterious.
The noncoding variants with the highest C-scores are described in the Supporting Information
(Table H in S1 File).
Discussion
This work describes the first whole-genome sequencing of a Serbian individual. Ancestry anal-
ysis positioned the Serbian individual in closest proximity to the Croatian population, consis-
tent with its Southern Slavic ancestry [69]. Our analyses further support the hypothesis of gene
flow between Neanderthal and pan-European ancestral populations, with the level of intro-
gression into the Serbian genome being within the range observed in other European popula-
tions. Previous genetic studies involving Slavic populations employed mitochondrial, Y-
chromosome and SNV-panel data to investigate the relationship between geographic, genetic
and linguistic distances [69, 70]. Consistent with this work, our analyses expand the scope
beyond Slavic populations and further contribute to the understanding of human genetic vari-
ation and its geographic distribution.
In contrast to studies using genotyping arrays [2, 3, 69, 70], the availability of whole-
genome sequences presents the opportunity for a high-resolution individualized analysis. To
this end, we found that the sequenced genome contains a significant number of previously
unobserved variants, which emphasizes the importance of continued sequencing of a large
number of individuals, especially from previously uncharacterized ethnic groups. Subsequent
sequencing of other Serbian individuals could provide further insight into these novel variants;
e.g., whether they are private to the population or to the individual. Such results would in turn
contribute important information regarding variants that are currently considered to be rare,
with implications for improved variant interpretation. Furthermore, new algorithms and
reduced sequencing costs will have the potential to provide higher-quality analysis of structural
variants. Our analysis also found a number of variants of clinical and pharmacogenomic sig-
nificance that might extend beyond an individual’s disease risks to facilitate possible future
medical interventions although conclusions are limited without validation and knowledge of
allele frequencies in the Serbian population [71, 72]. Such variants might contribute to better
outcomes in studies of disease penetrance, mechanistic understanding of population risks, and
database curation.
Recent advances in high-throughput sequencing and reduced costs of genotyping have
greatly facilitated whole-genome data generation, and have become key to understanding both
human phenotypes and early human history [2, 3]. However, modern technology and cost
structure continue to pose challenges in determining and interpreting one’s genome [73]. Var-
iation in read mapping and variant calling contribute to the uncertainty of interpretation with
different software packages, identifying different sets of variants. We found that inter-software
discrepancies ranged from relatively small for SNVs to considerable for insertions and dele-
tions, especially for structural variants. Therefore, variant and genome interpretation demand
caution, since thousands of SNVs and tens of thousands of indels may simply constitute geno-
typing errors [74, 75].
It is worth mentioning that in addition to the technical aspects of genome sequencing, an
important aspect of genome interpretation concerns psychosocial uncertainty due to pheno-
typic and privacy-associated risks [76]. The geographic distance analysis in this study has pro-
vided evidence that supports the individual’s own sense of Serbian ancestry; however, the
finding of multiple predicted youth-onset pathogenic mutations in a healthy individual pro-
vides cautionary lessons for predictive medicine.
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